Apoptosis induced by etoposide in small-cell lung cancer cell lines
- PMID: 8306412
- DOI: 10.1007/BF00686267
Apoptosis induced by etoposide in small-cell lung cancer cell lines
Abstract
The DNA fragmentation, a parameter of apoptosis, in non-small (NSCLC) and small (SCLC) cell lung cancer cell lines (N231 and PC-9) was evaluated. The DNA fragmentation in SCLC lines, but not in NSCLC lines, was observed in overgrown cells without exposure to anticancer drugs. In etoposide (VP-16)-treated N231 but not PC-9 cells, DNA fragmentation continued to increase up to 42 h, and the increase was dependent on the concentration of VP-16. The endonuclease activity of VP-16-treated N231, but not PC-9, cells required both Ca2+ and Mg2+ for full activity. It was elevated in a time- and concentration-dependent manner. As this activity was not affected by addition of cycloheximide, the activation of the endonuclease activity without protein synthesis may be involved in VP-16-induced cytotoxicity in N231.
Similar articles
-
Etoposide-induced cell cycle delay and arrest-dependent modulation of DNA topoisomerase II in small-cell lung cancer cells.Br J Cancer. 1994 Nov;70(5):914-21. doi: 10.1038/bjc.1994.420. Br J Cancer. 1994. PMID: 7947097 Free PMC article.
-
Topoisomerase inhibitor-induced apoptosis accompanied by down-regulation of Bcl-2 in human lung cancer cells.Anticancer Res. 2002 Nov-Dec;22(6C):4029-37. Anticancer Res. 2002. PMID: 12553028
-
Reduced expression of DNA topoisomerase II confers resistance to etoposide (VP-16) in small cell lung cancer cell lines established from a refractory tumor of a patient and by in vitro selection.Oncol Res. 1996;8(6):229-38. Oncol Res. 1996. PMID: 8895198
-
Topoisomerase II alpha content and topoisomerase II catalytic activity cannot explain drug sensitivities to topoisomerase II inhibitors in lung cancer cell lines.Cancer Chemother Pharmacol. 1997;39(3):192-8. doi: 10.1007/s002800050559. Cancer Chemother Pharmacol. 1997. PMID: 8996519
-
Synchronous primary lung cancer presenting with small cell carcinoma and non-small cell carcinoma: diagnosis and treatment.Oncol Rep. 1999 Jan-Feb;6(1):75-80. Oncol Rep. 1999. PMID: 9864405 Review.
Cited by
-
A topoisomerase II inhibitor, NK109, induces DNA single- and double-strand breaks and apoptosis.Jpn J Cancer Res. 1996 Oct;87(10):1086-91. doi: 10.1111/j.1349-7006.1996.tb03114.x. Jpn J Cancer Res. 1996. PMID: 8957068 Free PMC article.
-
EAT/mcl-1, a member of the bcl-2 related genes, confers resistance to apoptosis induced by cis-diammine dichloroplatinum (II) via a p53-independent pathway.Jpn J Cancer Res. 1998 Dec;89(12):1326-33. doi: 10.1111/j.1349-7006.1998.tb00530.x. Jpn J Cancer Res. 1998. PMID: 10081494 Free PMC article.
-
Up-regulation of telomerase activity in human pancreatic cancer cells after exposure to etoposide.Br J Cancer. 2000 Jun;82(11):1819-26. doi: 10.1054/bjoc.2000.1117. Br J Cancer. 2000. PMID: 10839297 Free PMC article.
-
ZMYM3 May Promote Cell Proliferation in Small Cell Lung Carcinoma.Acta Histochem Cytochem. 2021 Oct 29;54(5):143-153. doi: 10.1267/ahc.21-00012. Epub 2021 Oct 2. Acta Histochem Cytochem. 2021. PMID: 34764523 Free PMC article.
-
Effects of PI3K inhibitor NVP-BKM120 on overcoming drug resistance and eliminating cancer stem cells in human breast cancer cells.Cell Death Dis. 2015 Dec 17;6(12):e2020. doi: 10.1038/cddis.2015.363. Cell Death Dis. 2015. PMID: 26673665 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous